TSMC Stock Analysis: UBS Raises Target to T$3,400 Ahead of July 16 Q2 Earnings

Taiwan Semiconductor Manufacturing Co. (NYSE: TSM) received a price target increase from UBS to T$3,400 from T$3,000 Monday, with the Buy rating maintained, ahead of second-quarter earnings scheduled for July 16.

The U.S.-listed ADR price target based on TipRanks consensus now implies approximately 14.3% upside from $494.17. Wall Street expects EPS of $3.80 on revenue of $40.04 billion — compared to $2.47 EPS and $30.07 billion a year ago, a 33% revenue increase year-over-year driven by AI chip demand that TSMC's own CEO C.C. Wei described as "extremely robust."

The UBS upgrade carries one detail beyond the target revision that deserves specific attention: the firm believes TSMC could raise chip prices by early 2027.

What UBS Is Actually Saying

UBS is not simply raising a number. The firm is making a structural argument about TSMC's pricing power and capital cycle that runs through 2028. Three core claims underpin the upgrade.

First, demand visibility justifies multi-year capex commitment. UBS expects TSMC to keep increasing capital spending from 2026 through 2028 — the firm sees "higher capex commitment as critical to alleviating client concerns around supply constraints and the need for second-source diversification." TSMC's CEO has already flagged that 2026 capex will come in near the high end of the $52–$56 billion forecast range as AI chip demand keeps factories at near-full capacity.

Second, AI demand is broadening beyond GPU accelerators. UBS cited "stronger growth outlook across CPUs, accelerators, and potential edge AI applications" as likely to drive more capital expansion. This is the same broadening narrative that drove Qualcomm's Investor Day positioning and AMD's upward market forecast revision — the inference cycle is pulling demand into a wider set of chip types, all of which run through TSMC's most advanced nodes.

Third, a 2027 price hike is in view. This is the most commercially significant signal in the upgrade. TSMC has historically used targeted price increases to manage supply-demand imbalances and fund the investment cycles required to stay ahead on process technology. A signal that 2027 pricing negotiations may include rate increases suggests UBS believes TSMC's supply remains constrained enough to justify premium pricing — and that customers have no credible alternative source at the required performance levels.

What the Q2 Numbers Should Confirm

TSMC reported May 2026 revenue of T$416.98 billion, up 30.1% year-over-year. The Q2 consensus of $40.04 billion in revenue implies the quarterly run rate is tracking in line with or ahead of that monthly pace. The $3.80 EPS consensus represents a 54% increase from the $2.47 reported in Q2 2025 — a year-over-year earnings acceleration that reflects both revenue growth and the operating leverage inherent in a fab business running near capacity.

Three specific items will drive the post-earnings market reaction beyond the headline numbers: capex guidance for 2027–2028 (whether UBS's multi-year expansion thesis is confirmed by management's own numbers), commentary on Arizona and Japan fab yields (TSMC has consistently cited Arizona yields as comparable to Taiwan, and any softening of that claim would be significant), and competitive positioning commentary — UBS specifically expects TSMC to address concerns about Samsung Foundry, Intel 18A, and Terafab (Tesla's planned AI chip manufacturing facility using Intel technology), all of which represent potential second-source alternatives that customers are evaluating.

The Competitive Landscape TSMC Is Navigating

The second-source diversification concern UBS references is real and growing. TSMC supplies Apple, Nvidia, AMD, Qualcomm, and virtually every other advanced chip designer — a concentration that is strategically valuable but creates customer anxiety about sole-source dependency. The Intel-Apple announcement, the Foxconn-Intel AI infrastructure partnership, and Tesla's Terafab all represent customers and ecosystem players actively building alternatives to pure TSMC dependency.

TSMC's response is capacity expansion that makes sole-source dependency less existential by increasing available supply — and potentially price increases in 2027 that reflect its continued technical leadership and the irreplaceable nature of its most advanced nodes. Customers will pay more for N2 and A16 TSMC capacity if there is genuinely no equivalent from Samsung, Intel, or Terafab at the required yield, performance, and reliability levels.

TSMC at $494.17 with a $3.80 EPS consensus for Q2 and 14.3% upside to TipRanks' price target is a stock trading at a premium that its fundamental performance is currently earning. The July 16 earnings call is the first opportunity for management to validate UBS's 2027 price hike signal, confirm the high-end capex range, and address the competitive concerns that are building in the customer base.

A strong quarter with a constructive 2027 capex and pricing commentary would extend the bull case; any softening of the supply-constraint narrative — particularly around Arizona yields or HBM packaging capacity — would give bears their first credible entry point in what has been a structurally one-directional story for two years.

FAQ

• When does TSMC report Q2 earnings? July 16, 2026.

• What is the Q2 consensus? EPS of $3.80 on revenue of $40.04 billion — compared to $2.47 EPS and $30.07 billion a year ago.

• What is UBS's key new signal beyond the price target raise? The firm believes TSMC could raise chip prices by early 2027, reflecting continued supply constraints relative to AI-driven demand.

• What competitive concerns will TSMC address on the earnings call? UBS expects management to address Samsung Foundry, Intel 18A, and Terafab as potential second-source alternatives that customers are evaluating.

• What is the TipRanks consensus on TSM? Strong Buy — five Buys and one Hold — with an average price target implying approximately 14.3% upside from $494.17.